Research analysis of prostate cancer in Saudi Arabia

Karim Hamda Farhat; Abdulaziz Mohammed Althunayan; Danny Munther Rabah

doi:10.30574/ijsra.2025.14.3.0759

ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed

Peer Reviewed and Referred Journal || Free Certificate of Publication

Research and review articles are invited for publication in March 2026 (Volume 18, Issue 3) Submit manuscript

Research analysis of prostate cancer in Saudi Arabia

Karim Hamda Farhat ^{1, *}, Abdulaziz Mohammed Althunayan ^{1, 2} and Danny Munther Rabah ^{1, 2, 3}

¹ The Cancer Research Chair, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

² Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

³ Department of Urology, king Faisal specialist hospital and research Center, Riyadh, Saudi Arbia.

Review Article

International Journal of Science and Research Archive, 2025, 14(03), 890-893

Article DOI: 10.30574/ijsra.2025.14.3.0759

DOI url: https://doi.org/10.30574/ijsra.2025.14.3.0759

Publication history

Received on 09 February 2025; revised on 14 March 2025; accepted on 17 March 2025

Abstract

Prostate cancer (PCa) is an emerging public health concern in Saudi Arabia, with increasing incidence and significant challenges in early detection and management. This review summarizes current research on PCa in Saudi Arabia, covering its incidence, risk factors, treatment outcomes, screening practices, awareness, and recent advancements. We aim to offer a thorough understanding to healthcare professionals, policymakers, and the public. Data from observational studies, cancer registries, and clinical guidelines published between 2008 and 2024 were also reviewed. The incidence of prostate cancer is rising, with 752 new cases by 2022; however, it remains lower than that in Western countries. High metastasis rates at diagnosis (31.4%) and low screening uptake contribute to poor outcomes, with a 5-year survival rate of 49%. Treatment aligns with international standards; however, awareness and early detection lag. Enhanced screening and education are recommended to improve prognosis.

Keywords

Prostate cancer; Epidemiological trends; Risk factors; Treatment outcomes; Screening practices

Download Article PDF

https://journalijsra.com/sites/default/files/fulltext_pdf/IJSRA-2025-0759.pdf

Preview Article PDF

How to cite this article

Karim Hamda Farhat, Abdulaziz Mohammed Althunayan and Danny Munther Rabah. Research analysis of prostate cancer in Saudi Arabia. International Journal of Science and Research Archive, 2025, 14(03), 890-893. Article DOI: https://doi.org/10.30574/ijsra.2025.14.3.0759.

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.